• New funding to digitise info between health and social care pharmatimes
    July 10, 2018
    NHS Digital has announced new funding to facilitate digitising the flow of information between adult social care and health services.
  • Public backs NHS spending increases pharmatimes
    July 10, 2018
    An “overwhelming majority” of people support increasing spending on health and social care services, indicates a poll of 1,000 adults across Britain undertaken by Ipsos Mori for the NHS Confederation.
  • NHS should employ robots to save time and money, suggests finds pharmatimes
    July 10, 2018
    The NHS could free up frontline time worth up to £12.5 billion a year by fully embracing automation, such as employing robots at the bed side and care bots in the home, according to a new report led by former health minister Lord Darzi.
  • Vertex, NHS England no closer to Orkambi settlement pharmatimes
    July 10, 2018
    Vertex and NHS England remain locked in a battle over the provision of cystic fibrosis drug Orkambi, seemingly no closer to a settlement that would allow patients access to the drug on the NHS.
  • NHS England clears specialised treatments for NHS use pharmatimes
    July 10, 2018
    NHS England has approved routine funding for a stream of new specialised treatments, including stroke-reducing heart implants and a life changing surgical procedure for children with cerebral palsy.
  • GP continuity of care is slipping, finds study pharmatimes
    July 09, 2018
    A study published in the British Journal of General Practice has found that it is becoming increasingly difficult for patients to get appointments with their GP of choice.
  • High court rejects homeopathy plea pharmatimes
    July 06, 2018
    The High Court has rejected a legal challenge by the British Homeopathy Association to block plans to no longer routinely fund homeopathy on the NHS.
  • NICE rejects Janssen’s Zytiga for early, aggressive prostate cancer pharmatimes
    July 06, 2018
    It is looking unlikely that Janssen’s Zytiga plus androgen deprivation therapy (ADT) and prednisone/prednisolone will become routinely available on the NHS as a first-line treatment for patients with high-risk hormone-sensitive metastatic prostate cancer.
  • The July/August issue of Pharmafocus is now live! pharmafile
    July 06, 2018
    As cross- and inter-party squabbles ramp up and negotiations become ever more weighted with ominous importance, the day the UK will officially exit the European Union grows ever closer.
  • Survey shows public support for NHS tax rise pharmatimes
    July 06, 2018
    The vast majority of the public would be willing to accept tax increases to secure significant improvements in the NHS, finds a new poll by Ipos Mori commissioned by the NHS Confederation.
PharmaSources Customer Service